Búsqueda | Portal de Búsqueda de la BVS España

Wood, N I; Barone, F C; Benham, C D; Brown, T H; Campbell, C A; Cooper, D G; Evans, M L; Feuerstein, G Z; Hamilton, T C; Harries, M H; King, P D; Meakin, J E; Murkitt, K L; Patel, S R; Price, W J; Roberts, J C; Rothaul, A L; Samson, N A; Smith, S J; Hunter, A J.

J Cereb Blood Flow Metab; 17(4): 421-9, 1997 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-9143224

14.

Morphology and physiology of neurons in the rat perirhinal-lateral amygdala area.

Faulkner, B; Brown, T H.

J Comp Neurol; 411(4): 613-42, 1999 Sep 06.

Artículo en Inglés | MEDLINE | ID: mdl-10421872

15.

SB 201823-A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemia.

Benham, C D; Brown, T H; Cooper, D G; Evans, M L; Harries, M H; Herdon, H J; Meakin, J E; Murkitt, K L; Patel, S R; Roberts, J C.

Neuropharmacology; 32(11): 1249-57, 1993 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-8107976

16.

Reversible inhibitors of the gastric (H+/K+)-ATPase. 4. Identification of an inhibitor with an intermediate duration of action.

Leach, C A; Brown, T H; Ife, R J; Keeling, D J; Parsons, M E; Theobald, C J; Wiggall, K J.

J Med Chem; 38(14): 2748-62, 1995 Jul 07.

Artículo en Inglés | MEDLINE | ID: mdl-7629813

17.

Reversible inhibitors of the gastric (H+/K+)-ATPase. 5. Substituted 2,4-diaminoquinazolines and thienopyrimidines.

Ife, R J; Brown, T H; Blurton, P; Keeling, D J; Leach, C A; Meeson, M L; Parsons, M E; Theobald, C J.

J Med Chem; 38(14): 2763-73, 1995 Jul 07.

Artículo en Inglés | MEDLINE | ID: mdl-7629814

18.

Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1-Arylpyrrolo[3,2-c]quinolines: effect of the 4-substituent.

Leach, C A; Brown, T H; Ife, R J; Keeling, D J; Laing, S M; Parsons, M E; Price, C A; Wiggall, K J.

J Med Chem; 35(10): 1845-52, 1992 May 15.

Artículo en Inglés | MEDLINE | ID: mdl-1316968

19.

Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4-(phenylamino)quinolines.

Ife, R J; Brown, T H; Keeling, D J; Leach, C A; Meeson, M L; Parsons, M E; Reavill, D R; Theobald, C J; Wiggall, K J.

J Med Chem; 35(18): 3413-22, 1992 Sep 04.

Artículo en Inglés | MEDLINE | ID: mdl-1326634

20.

Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists.

Young, R C; Mitchell, R C; Brown, T H; Ganellin, C R; Griffiths, R; Jones, M; Rana, K K; Saunders, D; Smith, I R; Sore, N E.

J Med Chem; 31(3): 656-71, 1988 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-2894467

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Weekend admission and mortality for gastrointestinal disorders across England and Wales.

Tuberculous pancreatitis complicated by ruptured splenic artery pseudoaneurysm.

Giant synaptic potential hypothesis for epileptiform activity.

Differential conditioning of associative synaptic enhancement in hippocampal brain slices.

Long-term synaptic potentiation in the superior cervical ganglion.

Long-term synaptic potentiation.

Gastrointestinal bleeding in a pregnant woman: mucinous cystic neoplasm of pancreas mimicking gastrointestinal stromal tumor of stomach.

Seat belt injury causing delayed sigmoid colon fistula.

Auditory trace fear conditioning requires perirhinal cortex.

Fear conditioning to discontinuous auditory cues requires perirhinal cortical function.

Amygdalar nmda receptors are critical for the expression of multiple conditioned fear responses.

Predominance of late-spiking neurons in layer VI of rat perirhinal cortex.

The effects of SB 206284A, a novel neuronal calcium-channel antagonist, in models of cerebral ischemia.